Humana will release its second-quarter earnings later this month, and analysts anticipate a low single-digit profit dip.
Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible...
2026 investments focus on scaling community-based programs and funding innovative research to end senior loneliness
2 Healthcare Stocks with Competitive Advantages and 1 Facing Challenges
Health Insurance Providers Stocks Q1 Results: Benchmarking Humana (NYSE:HUM)
SAN FRANCISCO , June 23, 2026 /PRNewswire/ -- Schubert Jonckheer & Kolbe LLP advises Humana Inc. (NYSE: HUM) investors that the firm is investigating potential legal claims arising from alleged...
Humana Inc. (NYSE: HUM) will release its financial results for the second quarter 2026 (2Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on July 29, 2026. The company...
1 S&P 500 Stock on Our Buy List and 2 We Ignore
Led by Eli Lilly’s GLP-1 success, Humana’s expanding margins, and DexCom’s medtech growth, the healthcare sector is staging a major market rebound.
2 High-Flying Stocks to Target This Week and 1 Facing Challenges